What is the management approach for toxic alcohol ingestion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Toxic Alcohol Ingestion

Fomepizole is the preferred first-line antidote for toxic alcohol poisoning, with ethanol as an acceptable alternative when fomepizole is unavailable. 1, 2

Initial Assessment and Management

  • Immediately begin treatment upon suspicion of toxic alcohol ingestion based on patient history, anion gap metabolic acidosis, increased osmolar gap, visual disturbances, or oxalate crystals in urine 2
  • Assess for metabolic acidosis by checking anion gap, with values >27 mmol/L indicating severe poisoning 3
  • Evaluate for neurological symptoms, including altered mental status, seizures, or coma, which may appear early in poisoning 3
  • Check for signs of acute kidney injury, a common complication of glycol poisoning 3

Antidotal Therapy

  • Administer fomepizole as the preferred antidote to block alcohol dehydrogenase (ADH), preventing formation of toxic metabolites 1, 2
  • Fomepizole dosing regimen:
    • Loading dose: 15 mg/kg IV infused over 30 minutes 2
    • Maintenance: 10 mg/kg every 12 hours for 4 doses, then 15 mg/kg every 12 hours 2
    • Continue until toxic alcohol concentrations are <20 mg/dL and patient is asymptomatic with normal pH 2
  • If fomepizole is unavailable, ethanol may be used as an alternative ADH inhibitor, though it is less preferred due to:
    • Need for compounding in pharmacy 1
    • Increased risk of medication errors 1
    • Need for intensive monitoring 4
    • Potential sedative effects 4

Hemodialysis Considerations

  • Initiate hemodialysis in addition to ADH blockade for patients with: 2, 4
    • Renal failure 2
    • Significant or worsening metabolic acidosis 2
    • Toxic alcohol concentration ≥50 mg/dL 2
  • During hemodialysis, adjust fomepizole dosing to every 4 hours due to its dialyzability 2
  • Continue hemodialysis until toxic alcohol concentrations are <20 mg/dL and metabolic abnormalities are corrected 2

Monitoring and Supportive Care

  • Frequently monitor both toxic alcohol concentrations and acid-base balance using serum electrolytes (anion gap) and/or arterial blood gas analysis 2
  • Consider thiamine and pyridoxine as adjuvant therapy to support recovery, particularly in patients with suspected alcohol use disorder 3
  • Provide supportive care for organ dysfunction, particularly renal support if acute kidney injury develops 3
  • Monitor for alcohol withdrawal in patients with alcohol use disorder, especially during hemodialysis 3

Treatment Discontinuation

  • Treatment with fomepizole may be discontinued when: 2
    • Toxic alcohol concentrations are undetectable or <20 mg/dL 2
    • Patient is asymptomatic with normal pH 2

Special Considerations

  • Do not use polycarbonate syringes or polycarbonate-containing needles when administering fomepizole 2
  • Dilute fomepizole in at least 100 mL of sterile 0.9% sodium chloride or 5% dextrose solution 2
  • Fomepizole may solidify at temperatures below 25°C (77°F); if this occurs, liquefy by running the vial under warm water or holding in hand 2
  • Patients treated with fomepizole before onset of significant acidosis may not require hemodialysis, particularly in ethylene glycol poisoning 4

Clinical Outcomes

  • Early administration of fomepizole has been shown to prevent renal injury in ethylene glycol poisoning 4
  • In a systematic review, mortality rates for methanol poisoning were 17.1% with fomepizole versus 21.8% with ethanol; for ethylene glycol poisoning, mortality rates were 4.1% with fomepizole versus 18.1% with ethanol 5
  • All patients require immediate treatment as toxic alcohol poisoning can lead to accumulation of toxic metabolites causing metabolic acidosis, seizures, coma, and death if left untreated 2, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Ethoxydiglycol Exposure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Methanol and ethylene glycol intoxication.

Critical care clinics, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.